Inspiratory muscle training (IMT) produces beneficial effects in COPD subjects, but the effects of expiratory muscle training (EMT) and EMT plus IMT in ventilatory training are still unclear. The aim of this study was to systematically review the effects of EMT and EMT plus IMT compared to control groups of COPD subjects.
METHODS:
This study is a systematic review and meta-analysis. The search strategy included MEDLINE, Embase, LILACS, PEDro, and Cochrane CENTRAL and also manual search of references in published studies on the subject. Randomized trials comparing EMT and EMT plus IMT versus control groups of subjects with COPD were included. The outcomes analyzed were respiratory muscle strength and functional capacity. Two reviewers independently extracted the data.
RESULTS:
The search retrieved 609 articles. Five studies were included. We observed that EMT provided higher gain in maximum expiratory pressure (PEmax 21.49 cm H2O, 95% CI 13.39–29.59) and maximum inspiratory pressure (PImax 7.68 cm H2O, 95% CI 0.90–14.45) compared to control groups. There was no significant difference in the 6-min walk test distance (29.01 m, 95% CI −39.62 to 97.65) and dyspnea (0.15, 95% CI −0.77 to 1.08). In relation to EMT plus IMT, we observed that PEmax (31.98 cm H2O, 95% CI 26.93–37.03) and PImax (27.98 cm H2O, 95% CI 20.10–35.85) presented higher values compared to control groups.
CONCLUSIONS:
EMT and EMT plus IMT improve respiratory muscle strength and can be used as part of the treatment during pulmonary rehabilitation of subjects with severe to very severe COPD.
SinDD, AnthonisenNR, SorianoJB, AgustiAG. Mortality in COPD: role of comorbidities. Eur Respir J, 2006; 28(6):1245–1257.
2.
PereraPN, ArmstrongEP, SherrillDL, SkrepnekGH. Acute exacerbations of COPD in the United States: inpatient burden and predictors of costs and mortality. COPD, 2012; 9(2):131–141.
3.
AntunesFP, Costa MdaC, PaimJS, Vieira-da-SilvaLM, SantosCA, CruzAA, BarretoML. Trends in hospitalizations for respiratory diseases in Salvador, Bahia State, Brazil, 1998-2009. Cad Saude Publica, 2012; 28(5):869–877.
4.
WeinerP, MagadleR, BeckermanM, WeinerM, Berar-YanayN. Specific expiratory muscle training in COPD. Chest, 2003; 124(2):468–473.
5.
AgustíAG. Systemic effects of chronic obstructive pulmonary disease. Proc Am Thorac Soc, 2005; 2(4):367–370; discussion 371-362.
6.
SchererTA, SpenglerCM, OwassapianD, ImhofE, BoutellierU. Respiratory muscle endurance training in chronic obstructive pulmonary disease: impact on exercise capacity, dyspnea, and quality of life. Am J Respir Crit Care Med, 2000; 162(5):1709–1714.
7.
SalmanGF, MosierMC, BeasleyBW, CalkinsDR. Rehabilitation for patients with chronic obstructive pulmonary disease: meta-analysis of randomized controlled trials. J Gen Intern Med, 2003; 18(3):213–221.
8.
MotaS, GüellR, BarreiroE, SolanesI, Ramírez-SarmientoA, Orozco-LeviM, et al. Clinical outcomes of expiratory muscle training in severe COPD patients. Respir Med, 2007; 101(3):516–524.
9.
WeinerP, McConnellA. Respiratory muscle training in chronic obstructive pulmonary disease: inspiratory, expiratory, or both?. Curr Opin Pulm Med, 2005; 11(2):140–144.
10.
LöttersF, van TolB, KwakkelG, GosselinkR. Effects of controlled inspiratory muscle training in patients with COPD: a meta-analysis. Eur Respir J, 2002; 20(3):570–576.
11.
WeinerP, AzgadY, GanamR. Inspiratory muscle training combined with general exercise reconditioning in patients with COPD. Chest, 1992; 102(5):1351–1356.
12.
Ramirez-SarmientoA, Orozco-LeviM, GuellR, BarreiroE, HernandezN, MotaS, et al. Inspiratory muscle training in patients with chronic obstructive pulmonary disease: structural adaptation and physiologic outcomes. Am J Respir Crit Care Med, 2002; 166(11):1491–1497.
13.
WeinerP, MagadleR, BeckermanM, WeinerM, Berar-YanayN. Comparison of specific expiratory, inspiratory, and combined muscle training programs in COPD. Chest, 2003; 124(4):1357–1364.
14.
LangerD, HendriksE, BurtinC, ProbstV, van der SchansC, PatersonW, et al. A clinical practice guideline for physiotherapists treating patients with chronic obstructive pulmonary disease based on a systematic review of available evidence. Clin Rehab, 2009; 23(5):445–462.
15.
CrisafulliE, CostiS, FabbriLM, CliniEM. Respiratory muscles training in COPD patients. Int J Chron Obstruct Pulmon Dis, 2007; 2(1):19–25.
16.
HigginsJ, GreenS. Cochrane handbook for systematic reviews of interventions. England: Wiley; 2008.
17.
MoherD, LiberatiA, TetzlaffJ, AltmanDG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement. Open Med, 2009; 3(3):e123–e130.
18.
RobinsonKA, DickersinK. Development of a highly sensitive search strategy for the retrieval of reports of controlled trials using PubMed. Int J Epidemiol, 2002; 31(1):150–153.
NieldMA, Soo HooGW, RoperJM, SantiagoS. Efficacy of pursed-lips breathing: a breathing pattern retraining strategy for dyspnea reduction. J Cardiopulm Rehabil Prev, 2007; 27(4):237–244.
21.
BattagliaE, FulgenziA, FerreroME. Rationale of the combined use of inspiratory and expiratory devices in improving maximal inspiratory pressure and maximal expiratory pressure of patients with chronic obstructive pulmonary disease. Arch Phys Med Rehabil, 2009; 90(6):913–918.
22.
HodgevVA, KostianevSS. Maximal inspiratory pressure predicts mortality in patients with chronic obstructive pulmonary disease in a five-year follow-up. Folia Med, 2006; 48(3-4):36–41.
23.
VilaróJ, Ramirez-SarmientoA, Martínez-LlorensJM, MendozaT, AlvarezM, Sánchez-CayadoN, et al. Global muscle dysfunction as a risk factor of readmission to hospital due to COPD exacerbations. Respir Med, 2010; 104(12):1896–1902.
24.
MesquitaR, DonáriaL, GenzIC, PittaF, ProbstVS. Respiratory muscle strength during and after hospitalization for COPD exacerbation. Respir Care, 2013; 58(12):2142–2149.
25.
Soler-CataluñaJJ, Martínez-GarcíaMA, Román SánchezP, SalcedoE, NavarroM, OchandoR. Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax, 2005; 60(11):925–931.
26.
NinaneV, RypensF, YernaultJC, De TroyerA. Abdominal muscle use during breathing in patients with chronic airflow obstruction. Am Rev Respir Dis, 1992; 146(1):16–21.
27.
CastroAA, KümpelC, RangueriRC, OliveiraMD, DornellesRA, BritoER, et al. Daily activities are sufficient to induce dynamic pulmonary hyperinflation and dyspnea in chronic obstructive pulmonary disease patients. Clinics, 2012; 67(4):319–325.
28.
O'DonnellDE, D'ArsignyC, FitzpatrickM, WebbKA. Exercise hypercapnia in advanced chronic obstructive pulmonary disease: the role of lung hyperinflation. Am J Respir Crit Care Med, 2002; 166(5):663–668.
29.
O'DonnellDE, RevillSM, WebbKA. Dynamic hyperinflation and exercise intolerance in chronic obstructive pulmonary disease. Am J Respir Crit Care Med, 2001; 164(5):770–777.
30.
KesslerR, FallerM, FourgautG, MennecierB, WeitzenblumE. Predictive factors of hospitalization for acute exacerbation in a series of 64 patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med, 1999; 159(1):158–164.
31.
Pinto-PlataVM, CoteC, CabralH, TaylorJ, CelliBR. The 6-min walk distance: change over time and value as a predictor of survival in severe COPD. Eur Respir J, 2004; 23(1):28–33.
32.
NiciL, DonnerC, WoutersE, ZuwallackR, AmbrosinoN, BourbeauJ, et al. American Thoracic Society/European Respiratory Society statement on pulmonary rehabilitation. Am J Respir Crit Care Med, 2006; 173(12):1390–1413.
33.
IlliSK, HeldU, FrankI, SpenglerCM. Effect of respiratory muscle training on exercise performance in healthy individuals: a systematic review and meta-analysis. Sports Med, 2012; 42(8):707–724.
